首页> 中文期刊> 《癌症生物学与医学(英文版 )》 >Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes

Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes

         

摘要

Objective: There are no comprehensive studies on survival outcomes and optimal treatment protocols for cervical esophageal cancer(CEC), due to its rare clinical prevalence. Our objective was to determine the relationship between pathological characteristics, treatment protocols, and survival outcomes in Chinese CEC patients.Methods: A total of 500 Chinese CEC patients were selected from our 500,000 esophageal and gastric cardia carcinoma database(1973–2018). There were two main groups: patients treated with surgery, and patients receiving non-surgical treatments(radiotherapy, radiochemotherapy, and chemotherapy). The Chi-square test and Kaplan–Meier method were used to compare the continuous variables and survival.Results: Among the 500 CEC patients, 278(55.6%) were male, and the median age was 60.9 ± 9.4 years. A total of 496 patients(99.2%) were diagnosed with squamous cell carcinoma. In 171(34.2%) patients who received surgery, 22(12.9%) had undergone laryngectomy. In 322(64.4%) patients who received non-surgical treatments, 245(76.1%) received radiotherapy. Stratified survival analysis showed that only T stage was related with survival outcomes for CEC patients in the surgical group, and the outcomes between laryngectomy and non-laryngectomy patients were similar. It was noteworthy that the 5-year survival rate was similar in CEC patients among the different groups treated with surgery, radiotherapy, chemotherapy, or radiochemotherapy(P = 0.244). Conclusions: The CEC patients had similar survival outcomes after curative esophagectomy and radiotherapy, including those with or without total laryngectomy. These findings suggest that radiotherapy could be the initial choice for treatment of Chinese CEC patients.

著录项

  • 来源
    《癌症生物学与医学(英文版 )》 |2020年第1期|218-226|共9页
  • 作者单位

    State Key Laboratory of Esophageal Cancer Prevention & Treatment and Henan Key Laboratory for Esophageal Cancer Research of The First Affiliated Hospital Zhengzhou University Zhengzhou 450052 China;

    Department of Pathology and Pathophysiology School of Basic Medical Sciences Zhengzhou University Zhengzhou 450000 China;

    Department of Pathology Linzhou Esophageal Cancer Hospital Linzhou 456550 China;

    Department of Oncology Nanyang Central Hospital Nanyang 473000 China;

    Department of Thoracic Surgery Xinxiang Central Hospital Xinxiang 453000 China;

    Department of Oncology Anyang District Hospital Anyang 455000 China;

    Department of Thoracic Surgery Linzhou Center Hospital Linzhou 456550 China;

    Department of Oncology the First Affiliated Hospital of Zhengzhou University Zhengzhou 450000 China;

    Department of Gastroenterology The Second Affiliated Hospital of Nanyang Medical College Nanyang 473000 China;

    Department of Pathology Anyang Tumor Hospital Anyang 455000 China;

    Department of Radiotherapy The Affiliated Cancer Hospital of Zhengzhou University(Henan Cancer Hospital) Zhengzhou 450000 China;

    Department of Pathology The Second Affiliated Hospital of Zhengzhou University Zhengzhou 450000 China;

    Department of Pathology Hebei Provincial Cixian People's Hospital Cixian 056500 China;

    Department of Thoracic Surgery Anyang Tumor Hospital Anyang 455000 China;

    Department of Histology and Embryology School of Basic Medical Sciences Xinxiang Medical University Xinxiang 453000 China;

    Department of Thoracic Surgery Linzhou People's Hospital Linzhou 456550 China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号